Modeled Cmax is a PK→PD construct describing how absorption rate, absorption timing, solubility, gastric emptying, distribution loading, distribution geometry, and clearance shape rising-phase and peak-concentration geometry for sildenafil and avanafil. “Cmax” refers strictly to modeled PK→PD behavior, not real-world concentration. Absorption rate determines rising-phase steepness, absorption timing determines temporal alignment, solubility determines dissolution-driven availability, and gastric emptying determines input arrival. Distribution loading determines early central availability, while distribution geometry and clearance geometry determine how rapidly material spreads or is removed. First-pass metabolism determines the systemic fraction represented in the modeled circulation. These PK parameters generate concentration-time trajectories whose maximum defines modeled Cmax. PD interpretation then determines modeled peak geometry: threshold placement defines the onset boundary, binding sensitivity transforms concentration differences, coupling geometry shapes downstream transitions, and PD noise bands add interpretation variability. The resulting geometry separates concentration maxima from any real-world prediction.
Modeled Cmax-speed comparison follows the geometry of the concentration trajectory approaching its maximum. Faster modeled absorption steepens the rising phase, earlier absorption timing shifts that phase leftward, solubility determines dissolution-driven availability, and gastric-emptying variability shifts input arrival. Distribution loading determines early central-compartment concentration, while distribution geometry determines how rapidly absorbed material spreads across compartments and redistribution timing alters later compartmental equilibration. Clearance geometry determines removal dynamics. First-pass metabolism determines systemic fraction, while concentration-dependent clearance can alter curvature across the trajectory. These mechanisms interact: faster modeled absorption may be offset by faster modeled clearance, while earlier modeled timing may be offset by broader distribution geometry. Under peak modeling, PK geometry supplies the concentration-time curve that PD parameters transform. The resulting Cmax and Tmax coordinates are properties of the specified model, allowing sildenafil and avanafil parameter sets to be compared as geometric trajectories rather than as real-world concentration or performance predictions.
PD geometry shapes modeled Cmax-speed comparison by transforming the PK trajectory through defined concentration-response relationships. Threshold placement determines where the PK curve intersects a modeled PD boundary, while binding sensitivity determines how concentration differences are translated into binding differences; higher modeled sensitivity can expand separation, while lower sensitivity can compress it. Coupling geometry determines how binding is mapped into downstream PD signals; shallow slopes broaden transitions, while steep slopes compress them. PD noise bands widen or narrow interpretation regions around the transformed trajectory. Because sildenafil and avanafil can be represented by differing parameter sets for absorption rate, solubility, gastric emptying, distribution loading, distribution geometry, redistribution timing, clearance geometry, and Tmax/Cmax geometry, the resulting PK→PD mapping can expand or compress modeled Cmax-speed differences. In this framework, peak speed describes trajectory geometry, not real-world speed, and Cmax remains a model-defined concentration maximum rather than a real-world prediction.
PK geometry determines the modeled concentration trajectory used for Cmax comparison. Absorption rate controls the steepness of the incoming phase, while absorption timing determines its temporal alignment. Solubility influences dissolution-driven availability, and gastric emptying controls when gastrointestinal input reaches the absorption region. Absorption-window width determines whether input is concentrated into a narrow interval or distributed across a broader interval. Distribution loading determines initial central-compartment availability, while distribution geometry controls compartmental spread and equilibration. Redistribution timing can shift later concentration relationships relative to the initial peak approach. First-pass metabolism and bioavailability determine the systemic fraction represented after input processing. Clearance geometry controls removal and therefore influences whether concentration continues rising or begins declining. Concentration-dependent clearance can further alter curvature as concentration changes. Tmax geometry emerges from the location of the modeled maximum, while Cmax geometry describes its magnitude and surrounding curve shape. Together, these parameters define the PK peak trajectory without implying an observed or predicted real-world concentration. See the absorption rate construct.
PK variability can be represented by changing parameter values across modeled trajectories. Variation in absorption rate changes rising-phase steepness, while variation in absorption timing shifts the trajectory along the model clock. Gastric-emptying variation changes input arrival, and solubility variation changes dissolution-driven availability. A wider or narrower absorption window changes how concentrated the incoming phase becomes. Distribution loading, distribution geometry, and redistribution timing alter early and intermediate concentration placement. First-pass metabolism and bioavailability change the systemic fraction represented in the trajectory. Clearance geometry changes the balance between continued accumulation and removal, while concentration-dependent clearance can modify curvature around higher modeled concentrations. These interacting parameters can produce narrow, broad, steep, shallow, early-shifted, or late-shifted modeled Cmax windows. Tmax can move as the maximum shifts, while Cmax can change as the trajectory rises or falls differently. The resulting spread describes parameterized PK geometry, not real-world variability or a prediction of actual concentration. See the distribution speed construct.
| PK Domain | Cmax Interaction | Link |
|---|---|---|
| Absorption Rate | Steeper rising phase. | absorption rate |
| Distribution Geometry | Compartmental spread. | distribution speed |
| Clearance | Removal geometry. | elimination speed |
Threshold placement modifies the modeled peak-time relationship by defining a concentration boundary against which the PK trajectory is interpreted. Moving the threshold changes where the rising or transformed trajectory intersects that boundary, which can shift a modeled timing coordinate even when the underlying PK curve remains unchanged. Binding sensitivity then determines how concentration differences are translated into modeled binding differences. Coupling geometry maps those binding differences into a downstream PD signal and can change the apparent slope or curvature surrounding the modeled peak. PD noise bands represent a modeled interpretation region around that transformed signal, allowing closely spaced trajectories to overlap or remain distinct. These mechanisms operate on the PK trajectory rather than replacing it. Consequently, two identical concentration-time profiles can yield different modeled peak-time geometries under different PD parameterizations, while different PK profiles can converge after PD transformation. The pd speed construct frames these effects as model geometry rather than real-world timing.
Binding sensitivity, coupling geometry, and PD noise bands determine how PK differences appear after concentration is transformed through the PD model. Binding sensitivity controls the modeled magnitude of binding change associated with a concentration difference, so higher sensitivity can enlarge trajectory separation while lower sensitivity can compress it. Coupling geometry determines how binding is transferred into a downstream signal, with slope and curvature controlling transition shape. PD noise bands add a modeled spread around that signal, potentially making closely spaced trajectories overlap or making separated trajectories appear less sharply distinguished. Threshold placement can further change which portions of the concentration trajectory are emphasized in the modeled interpretation. These modifiers can therefore amplify, compress, broaden, or shift the apparent geometry associated with Cmax and peak timing without changing the underlying PK parameter values. The pk speed construct supplies the concentration-time geometry that this PD layer transforms.
| PD Domain | Cmax Effect | Link |
|---|---|---|
| Threshold Placement | Earlier/later peak. | peak time |
| Binding Sensitivity | Amplification/compression. | peak variability comparison |
| Coupling Geometry | Slope-driven shaping. | onset variability comparison |
Modeled Cmax-speed differences arise from parameterized PK trajectories and PD transformation. Absorption rate, absorption timing, gastric emptying, solubility, and absorption-window width shape the rising concentration phase. Distribution loading, distribution geometry, and redistribution timing shape concentration placement across compartments. First-pass metabolism and bioavailability determine the systemic fraction represented in the modeled circulation, while clearance geometry and concentration-dependent clearance shape removal and curvature. Tmax identifies the modeled location of maximum concentration, while Cmax identifies the modeled maximum concentration. The PD layer then applies threshold placement, binding sensitivity, coupling geometry, and noise bands to transform concentration differences into modeled peak geometry. Parameter combinations can produce similar modeled maxima through different mechanisms, while small parameter changes can alter peak shape when other mechanisms do not compensate. The comparison therefore concerns specified model trajectories.
The principal PK mechanisms shaping Cmax are absorption rate, absorption timing, gastric emptying, solubility, absorption-window width, distribution loading, distribution geometry, redistribution timing, first-pass metabolism, bioavailability, clearance geometry, concentration-dependent clearance, Tmax geometry, and Cmax geometry. Absorption establishes the timing and shape of incoming material, while distribution determines compartmental allocation and redistribution. First-pass metabolism and bioavailability determine the systemic fraction represented after input processing. Clearance determines removal and can modify concentration curvature. Tmax identifies the modeled time coordinate of the maximum, while Cmax identifies the modeled concentration value at that maximum. These mechanisms interact rather than operating as independent switches. Their combined geometry determines the modeled peak trajectory, and Cmax comparison evaluates that parameterized concentration-time profile.
PD mechanisms shape modeled peak concentration by determining how the PK trajectory is interpreted after concentration enters the PD layer. Threshold placement establishes a defined concentration boundary, so moving that boundary changes its intersection with the trajectory. Binding sensitivity determines how concentration differences are converted into modeled binding differences and controls separation between transformed trajectories. Coupling geometry maps binding into a downstream PD signal, with slope and curvature influencing transition shape. PD noise bands introduce a modeled spread around the transformed signal, allowing trajectories to overlap or remain distinct. The resulting peak geometry is not determined by Cmax alone. A concentration maximum can be transformed differently under different PD parameterizations. In this framework, peak concentration remains a model-defined construct, while PD parameters determine how its geometry is represented.
Sildenafil and avanafil can differ in modeled Cmax geometry when their parameter sets assign different values or functional forms to absorption, distribution, metabolism, clearance, and PD transformation. Differences in absorption rate or timing can change the slope and alignment of the rising phase. Gastric-emptying and solubility parameters can alter modeled input arrival and availability, while absorption-window width can broaden or narrow the incoming phase. Distribution loading, distribution geometry, and redistribution timing can modify concentration placement around the maximum. First-pass metabolism and bioavailability can alter the systemic fraction, while clearance geometry can reshape the approach to and departure from the maximum. At the PD level, threshold placement, binding sensitivity, coupling geometry, and noise bands can transform those PK differences into different modeled peak geometries. The comparison reflects the specified parameterization and model structure used for the modeled trajectories.
PK→PD mapping explains modeled Cmax-speed differences by treating the PK concentration-time trajectory as an input to a defined PD transformation. PK parameters determine the trajectory: absorption controls the incoming phase, distribution controls compartmental allocation, first-pass processes determine systemic availability, and clearance controls removal. Tmax and Cmax emerge as geometric descriptors of that trajectory. The PD layer then places a threshold on concentration, applies binding sensitivity, maps binding through coupling geometry, and can add a noise band around the resulting signal. A small PK shift can produce a large or small modeled separation change depending on threshold location and transformation slope. The final Cmax-speed geometry is a property of the combined PK and PD model. It describes parameterized trajectories approaching a modeled concentration maximum, without converting that geometry into an observed real-world Cmax or peak-speed prediction.